Carola A.S. Arndt, MD

Professor

  • 6434 Citations
  • 38 h-Index
1981 …2018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Rhabdomyosarcoma Medicine & Life Sciences
Osteosarcoma Medicine & Life Sciences
Vincristine Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Ifosfamide Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Cyclophosphamide Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1981 2002

CHILDRENS CANCER GROUP

Arndt, C. A. S.

National Institutes of Health

1/1/8111/30/02

Project: Research projectCooperative Clinical Research--Cooperative Agreements

Neoplasms
Epidemiology
Research Personnel
Pharmacology
Committee Membership

Research Output 1986 2018

  • 6434 Citations
  • 38 h-Index
  • 110 Article
  • 7 Review article
  • 3 Letter
  • 2 Comment/debate

Addition of vincristine and irinotecan to vincristine, dactinomycin, and cyclophosphamide does not improve outcome for intermediate-risk rhabdomyosarcoma: A report from the children’s oncology group

Hawkins, D. S., Chi, Y. Y., Anderson, J. R., Tian, J., Arndt, C. A. S., Bomgaars, L., Donaldson, S. S., Hayes-Jordan, A., Mascarenhas, L., Mccarville, M. B., Mccune, J. S., Mccowage, G., Million, L., Morris, C. D., Parham, D. M., Rodeberg, D. A., Rudzinski, E. R., Shnorhavorian, M., Spunt, S. L., Skapek, S. X. & 4 othersTeot, L. A., Wolden, S., Yock, T. I. & Meyer, W. H., Sep 20 2018, In : Journal of Clinical Oncology. 36, 27, p. 2770-2777 8 p.

Research output: Contribution to journalArticle

irinotecan
Rhabdomyosarcoma
Dactinomycin
Vincristine
Cyclophosphamide

Fifty years of rhabdomyosarcoma studies on both sides of the pond and lessons learned

Arndt, C. A. S., Bisogno, G. & Koscielniak, E., Jul 1 2018, In : Cancer Treatment Reviews. 68, p. 94-101 8 p.

Research output: Contribution to journalReview article

Rhabdomyosarcoma
Alkylating Agents
Drug Therapy
Ifosfamide
Dactinomycin

Hyperbaric oxygen as a treatment modality in cyclophosphamide-induced hemorrhagic cystitis

Kaur, D., Khan, S. P., Rodriguez, V., Arndt, C. A. S. & Claus, P., Jan 1 2018, (Accepted/In press) In : Pediatric Transplantation.

Research output: Contribution to journalArticle

Cystitis
Cyclophosphamide
Oxygen
Urinary Bladder
Acrolein

Letter to Dr Pierre Russo, Editor of Pediatric and Developmental Pathology, 2017

Raney, R. B., Arndt, C. A. S. & Parham, D. M., Jan 1 2018, (Accepted/In press) In : Pediatric and Developmental Pathology.

Research output: Contribution to journalArticle

Pediatrics
Pathology

Localized vaginal/uterine rhabdomyosarcoma-results of a pooled analysis from four international cooperative groups

Minard-Colin, V., Walterhouse, D., Bisogno, G., Martelli, H., Anderson, J., Rodeberg, D. A., Ferrari, A., Jenney, M., Wolden, S., De Salvo, G., Arndt, C. A. S., Merks, J. H. M., Gallego, S., Schwob, D., Haie-Meder, C., Bergeron, C., Stevens, M. C. G., Oberlin, O. & Hawkins, D., Jan 1 2018, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

Rhabdomyosarcoma
Radiotherapy
Sarcoma
Brachytherapy
Pediatrics